Certara stock.

Craig Rayner CERT stock SEC Form 4 insiders trading. Craig has made over 2 trades of the Certara stock since 2021, according to the Form 4 filled with the SEC. Most recently Craig sold 54,462 units of CERT stock worth $1,978,604 on 2 September 2021.. The largest trade Craig's ever made was selling 108,924 units of Certara stock on 11 …Certara Inc. stock grades by Barron's. ... Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings.Complete Certara Inc. stock information by Barron's. View real-time CERT stock price and news, along with industry-best analysis. 54.33%. Get the latest Certara Inc (CERT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Mar 22, 2021 · Certara, Inc. (“Certara”), a global leader in biosimulation, today announced a proposed underwritten public offering of 17 million shares of its common stock being offered by selling stockholders. Additionally, the selling stockholders intend to grant the underwriters a 30-day option to purchase up to 2,550,000 additional shares of common ...

Ms Choe CERT stock SEC Form 4 insiders trading. Ms has made over 7 trades of the Certara stock since 2021, according to the Form 4 filled with the SEC. Most recently she sold 7,500 units of CERT stock worth $210,000 on 20 December 2021.. The largest trade she's ever made was selling 20,000 units of Certara stock on 19 November …Find real-time CERT - Certara Inc stock quotes, company profile, news and forecasts from CNN Business.

Mar 24, 2021 · Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the pricing of its underwritten public offering of 10 million shares of its common stock by certain existing stockholders (“the selling stockholders”) at a price to the public of $25.00 per share. Additionally, the selling stockholders have granted the ... Nov 17, 2021 · November 17, 2021. PRINCETON, N.J., November 17, 2021. — Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the pricing of its underwritten public offering of 10 million shares of its common stock by certain existing stockholders (the “selling stockholders”) at a price to the public of $31.00 per share.

Nov 10, 2023 · Certara Inc’s Stock Price as of Market Close. As of November 10, 2023, 4:00 PM, CST, Certara Inc’s stock price was $13.50. Certara Inc is up 6.72% from its previous closing price of $12.65. During the last market session, Certara Inc’s stock traded between $12.61 and $13.36. Currently, there are 159.17 million shares of Certara Inc stock ... 1.90%. $360.63M. Adtran Networks SE. 0.50%. €1.02B. CIEN | Complete Ciena Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Mar 22, 2021 · Certara, Inc. (“Certara”), a global leader in biosimulation, today announced a proposed underwritten public offering of 17 million shares of its common stock being offered by selling stockholders. Additionally, the selling stockholders intend to grant the underwriters a 30-day option to purchase up to 2,550,000 additional shares of common ... Presentation Operator MessageOperator Good day, and thank you for standing by. Welcome to the Certara Third Quarter 2023 Earnings Conference Call. [Operator Instructions] ... Stock Certara, Inc. - Nasdaq . News Certara, Inc. Transcript : Certara, Inc., Q3 2023 Earnings Call, Nov 08, 2023. CATEGORIES. Indexes; Equities ...Certara Inc CERT:US Nasdaq GS (USD) Delayed price as of 2:59 PM EST 11/21/23. Market open. 14.45 –0.27 –1.80% Prev. close 14.71 USD 14.45 USD 3:00 PM …

4 Apr 2023 ... Certara (CERT), a developer of biosimulation software for drug discovery, dropped Tuesday after Barclays downgraded on valuation concerns.

Nov 22, 2021 · PRINCETON, N.J.—November 22, 2021– Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the closing of its underwritten public offering of 10,000,000 shares of its common stock by certain existing stockholders at a public offering price of $31.00 per share.

Biosimulation can reduce the size of and cost of human trials, the most expensive and time-consuming part of drug development. In some cases, we can eliminate certain human trials completely. More than 2,000 customers worldwide choose us as their partner for biosimulation software and technology-driven services.Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.5 brokerages have issued 1-year price objectives for Elanco Animal Health's stock. Their ELAN share price targets range from $9.50 to $16.00. On average, they anticipate the company's share price to reach …22 Nov 2023 ... Certara accelerates medicines to patients using proprietary biosimulation ... Share. Save. Report. Comments. thumbnail-image. Add a comment...The Nasdaq Stock Market LLC Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing …

Success is Achieved Together. Biosimulation can reduce the size of and cost of human trials, the most expensive and time-consuming part of drug development. In some cases, we can eliminate certain human trials completely. More than 2,000 customers worldwide choose us as their partner for biosimulation software and technology-driven services. Arena Pharmaceuticals. 22-Feb-1999. Later Stage VC. 0000. Completed. 5 buyers. To view Certara’s complete exits history, request access ». Information on stock, financials, earnings, subsidiaries, investors, and executives for Certara. Use the PitchBook Platform to explore the full profile. 16 Des 2020 ... Certara today announced that it closed its upsized initial public offering of 33413250 shares of common stock at $23.00 per share.10 Des 2020 ... (Reuters) -U.S. drug development consultancy Certara Inc said on Thursday it sold shares in its initial public offering at $23 apiece, ...Discover historical prices for CERT stock on Yahoo Finance. View daily, weekly or monthly format back to when Certara, Inc. stock was issued. ... Certara, Inc. (CERT) NasdaqGS - NasdaqGS Real Time ... Here are 5 tips to streamline developing a detailed SOC that will help relieve some of the last-minute stress: 1. During the kickoff meeting, ask your regulatory affairs representative whether a detailed SOC is required. Frequently, a high-level overview of changes and the rationale for these changes is sufficient.

Nov 21, 2023 · Certara, Inc. is a provider of biosimulation software and technology-enabled services. The Company is focused on producing medicines for patients using biosimulation software, technology, and services to transform traditional drug discovery and development.

How much is Certara stock worth today? ( NASDAQ: CERT) Certara currently has 159,844,780 outstanding shares. With Certara stock trading at $14.64 per share, the total value of Certara stock (market capitalization) is $2.34B. Certara stock was originally listed at a price of $33.59 in Dec 14, 2020.Robert has made over 7 trades of the Certara stock since 2021, according to the Form 4 filled with the SEC. Most recently Robert exercised 8,646 units of CERT stock worth $166,436 on 31 March 2023.At closing, equity holders of Pinnacle 21 received approximately $250 million in cash consideration and 2,239,717 shares of Certara restricted common stock, subject to certain customary closing adjustments. The transaction is expected to be accretive to Certara’s revenue, revenue growth, and adjusted EBITDA.Nasdaq | CERT U.S.: Nasdaq Certara Inc. Watch list NEW Set a price target alert After Hours Last Updated: Nov 24, 2023 2:28 p.m. EST Delayed quote $ 15.20 0.23 1.54% After Hours Volume: 2.55K... The company had revenue of $85.58 million for the quarter, compared to analyst estimates of $85.96 million. Certara has generated ($0.21) earnings per share over the last year (($0.21) diluted earnings per share). Earnings for Certara are expected to decrease by -9.09% in the coming year, from $0.33 to $0.30 per share.11 Okt 2023 ... 11, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial ...The average twelve-month price prediction for Air Products and Chemicals is $320.31 with a high price target of $360.00 and a low price target of $240.00. Learn more on APD's analyst rating history. Do Wall Street analysts like Air Products and Chemicals more than its competitors?

A high-level overview of Twilio Inc. (TWLO) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Nov 21, 2023 · Certara, Inc. is a provider of biosimulation software and technology-enabled services. The Company is focused on producing medicines for patients using biosimulation software, technology, and services to transform traditional drug discovery and development.

Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...Arsenal will acquire approximately 30M shares at $15 per share from funds controlled by EQT Private Equity and agrees to two-year lock-up on sale of shares. PRINCETON, N.J.— November 7, 2022 — Certara, Inc. (Nasdaq: CERT) today announced that Arsenal Capital Partners (“Arsenal”), a private equity firm specializing in investing in and building transformational healthcare companies, has ...Certara, Inc. is a provider of biosimulation software and technology-enabled services. The Company is focused on producing medicines for patients using biosimulation software, technology, and services to transform traditional drug discovery and development.While strong estimate revisions for Certara, Inc. have attracted decent investments and pushed the stock 13.2% higher over the past four weeks, further upside may still be left in the stock.CERT Certara, Inc. Stock Price & Overview 2.67K followers $14.64 0.23 ( +1.60%) 4:00 PM 12/01/23 NASDAQ | $USD | Post-Market: $14.64 4:03 PM Summary …Certara (CERT) stock rose ~15% on Thursday after Q4 results beat estimates and the company's FY23 outlook range surpassed analysts expectations.Adjusted EPS grew +166.6% Y/Y to $0.16,...The estimated Net Worth of Leif E Pedersen is at least $5.54 Миллион dollars as of 11 September 2023. Mr Pedersen owns over 51,224 units of Certara stock worth over $1,929,379 and over the last 3 years he sold CERT stock worth over $3,311,582. In addition, he makes $295,397 as Pres of Software at Certara.As of now, Certara’s stock opened at $18.19 on Friday, with a market cap of $2.91 billion. The company has a price-to-earnings ratio of 202.11 and a price-to-earnings-growth ratio of 0.96, indicating the market’s confidence in its future growth potential. Certara’s beta stands at 1.58, reflecting its sensitivity to market volatility.Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the pricing of its underwritten public offering of 10 million shares of its common stock by certain existing stockholders (“the selling stockholders”) at a price to the public of $25.00 per share. Additionally, the selling stockholders have granted the ...

When picking the best stocks under $10 to buy, it's important to identify fundamentally strong and non-speculative stocks. These are fundamentally strong and non-speculative stocks that are under $10 Since the meme stock euphoria in 2020, i...If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.Oct 4, 2021 · At closing, equity holders of Pinnacle 21 received approximately $250 million in cash consideration and 2,239,717 shares of Certara restricted common stock, subject to certain customary closing adjustments. The transaction is expected to be accretive to Certara’s revenue, revenue growth, and adjusted EBITDA. Instagram:https://instagram. option paper tradingbuy cresco labs stockwebull cash account optionsmr cooper rates About Certara Certara accelerates medicines using biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,300 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries. Learn more at Certara.com. Certara Contact: quarters worth more moneyasx ltd asx Reiterating 2023 Financial Outlook. Certara continues to expect the following: Full year 2023 revenue to be in the range of $370 million to $385 million. Full year 2023 adjusted EBITDA to be in the range of $131 million to $137 million. Full year adjusted diluted earnings per share to be in the range of $0.50 - $0.55. splash loan reviews Certara Inc Ordinary Shares 700 Morningstar Rating Unlock Stock XBER Rating as of Nov 17, 2023 Summary Chart News Price vs Fair Value Sustainability Trailing Returns Financials Valuation...Find real-time CERT - Certara Inc stock quotes, company profile, news and forecasts from CNN Business.Josh Xie is Director-Clinical Pharmacology at Certara, Inc. ... Stock quotes are provided by Factset, Morningstar and S&P Capital IQ Stock markets for all 100% Free Registration. 100% Free Registration